Sera Prognostics, Inc. (NASDAQ:SERA - Get Free Report) insider John J. Boniface sold 24,474 shares of the company's stock in a transaction that occurred on Thursday, March 28th. The shares were sold at an average price of $9.04, for a total value of $221,244.96. Following the completion of the transaction, the insider now owns 139,771 shares in the company, valued at approximately $1,263,529.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Sera Prognostics Price Performance
SERA opened at $9.10 on Friday. Sera Prognostics, Inc. has a 52 week low of $1.52 and a 52 week high of $10.44. The business's fifty day simple moving average is $8.47 and its 200 day simple moving average is $5.03.
Hedge Funds Weigh In On Sera Prognostics
A number of institutional investors have recently bought and sold shares of SERA. Sanders Morris Harris LLC increased its stake in shares of Sera Prognostics by 22.6% during the third quarter. Sanders Morris Harris LLC now owns 445,105 shares of the company's stock valued at $828,000 after purchasing an additional 81,933 shares in the last quarter. Resource Consulting Group Inc. bought a new position in shares of Sera Prognostics during the fourth quarter valued at approximately $265,000. Squarepoint Ops LLC bought a new position in shares of Sera Prognostics during the first quarter valued at approximately $65,000. Bank of New York Mellon Corp bought a new position in shares of Sera Prognostics during the first quarter valued at approximately $50,000. Finally, Charles Schwab Investment Management Inc. bought a new position in shares of Sera Prognostics during the first quarter valued at approximately $46,000. 54.64% of the stock is owned by institutional investors.
Sera Prognostics Company Profile
(
Get Free Report)
Urgent Nvidia Warning
From Altimetry | Ad
Could Steve Job's 'Final Prophecy' Make You Rich?
Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.
Click here to access…
Sera Prognostics, Inc, a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
